Literature DB >> 17047146

The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation.

Florian Diehl1, Lothar Rössig, Andreas M Zeiher, Stefanie Dimmeler, Carmen Urbich.   

Abstract

Posttranslational histone modification by acetylation or methylation regulates gene expression. Here, we investigated the role of the histone lysine methyltransferase MLL for angiogenic functions in human umbilical vein endothelial cells. Suppression of MLL expression by siRNA or incubation with the pharmacologic methyltransferase inhibitor 5'-deoxy-5'-(methylthio)adenosine significantly decreased endothelial-cell migration and capillary sprout formation, indicating that methyltransferase activity is required for proangiogenic endothelial-cell functions. Because the expression of homeodomain transcription factors (Hox) is regulated by MLL, we elucidated the role of Hox gene expression. MLL silencing was associated with reduced mRNA and protein expression of HoxA9 and HoxD3, whereas HoxB3, HoxB4, HoxB5, and HoxB9 were not altered. Overexpression of HoxA9 or HoxD3 partially compensated for impaired migration in MLL siRNA-transfected endothelial cells, suggesting that HoxA9 and HoxD3 both contribute to MLL-dependent migration. As a potential underlying mechanism, MLL siRNA down-regulated mRNA and protein levels of the HoxA9-dependent axon guidance factor EphB4. In contrast, MLL knockdown effects on capillary sprouting were not rescued by HoxA9 or HoxD3 overexpression, indicating that MLL affects additional targets required for 3-dimensional sprout formation. We conclude that MLL regulates endothelial-cell migration via HoxA9 and EphB4, whereas sprout formation requires MLL-dependent signals beyond HoxA9 and HoxD3.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047146     DOI: 10.1182/blood-2006-08-039651

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.

Authors:  Stephen A Shinsky; Michael Hu; Valarie E Vought; Sarah B Ng; Michael J Bamshad; Jay Shendure; Michael S Cosgrove
Journal:  J Mol Biol       Date:  2014-03-27       Impact factor: 5.469

Review 2.  Chemical probes for histone-modifying enzymes.

Authors:  Philip A Cole
Journal:  Nat Chem Biol       Date:  2008-10       Impact factor: 15.040

3.  Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin.

Authors:  David Kaluza; Jens Kroll; Sabine Gesierich; Tso-Pang Yao; Reinier A Boon; Eduard Hergenreider; Marc Tjwa; Lothar Rössig; Edward Seto; Hellmut G Augustin; Andreas M Zeiher; Stefanie Dimmeler; Carmen Urbich
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

4.  A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.

Authors:  Clara Bueno; Rosa Montes; Gustavo J Melen; Verónica Ramos-Mejia; Pedro J Real; Verónica Ayllón; Laura Sanchez; Gertrudis Ligero; Iván Gutierrez-Aranda; Agustín F Fernández; Mario F Fraga; Inmaculada Moreno-Gimeno; Deborah Burks; María del Carmen Plaza-Calonge; Juan C Rodríguez-Manzaneque; Pablo Menendez
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

Review 5.  Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia.

Authors:  Qingyi Ma; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2014-11-11       Impact factor: 11.685

6.  Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.

Authors:  Konstantinos Stellos; Aikaterini Gatsiou; Kimon Stamatelopoulos; Ljubica Perisic Matic; David John; Federica Francesca Lunella; Nicolas Jaé; Oliver Rossbach; Carolin Amrhein; Frangiska Sigala; Reinier A Boon; Boris Fürtig; Yosif Manavski; Xintian You; Shizuka Uchida; Till Keller; Jes-Niels Boeckel; Anders Franco-Cereceda; Lars Maegdefessel; Wei Chen; Harald Schwalbe; Albrecht Bindereif; Per Eriksson; Ulf Hedin; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Nat Med       Date:  2016-09-05       Impact factor: 53.440

7.  Cardiac deletion of Smyd2 is dispensable for mouse heart development.

Authors:  Florian Diehl; Mark A Brown; Machteld J van Amerongen; Tatyana Novoyatleva; Astrid Wietelmann; June Harriss; Fulvia Ferrazzi; Thomas Böttger; Richard P Harvey; Philip W Tucker; Felix B Engel
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

8.  HOX proteins and leukemia.

Authors:  Kajal V Sitwala; Monisha N Dandekar; Jay L Hess
Journal:  Int J Clin Exp Pathol       Date:  2008-03-30

9.  HOXA9 participates in the transcriptional activation of E-selectin in endothelial cells.

Authors:  Smarajit Bandyopadhyay; Mohammad Z Ashraf; Pamela Daher; Philip H Howe; Paul E DiCorleto
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

10.  BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression.

Authors:  Phuongmai Nguyen; Gil Bar-Sela; Lunching Sun; Kheem S Bisht; Hengmi Cui; Elise Kohn; Andrew P Feinberg; David Gius
Journal:  Mol Cell Biol       Date:  2008-09-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.